Roy Buchanan Analyst PerformanceAnalyst at JMP SecuritiesRoy Buchanan is a stock analyst at JMP Securities focused in the medical sector, covering 20 publicly traded companies. Over the past year, Roy Buchanan has issued 26 stock ratings, including buy and hold recommendations. While full access to Roy Buchanan's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Roy Buchanan's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings53 Last 10 YearsBuy Recommendations92.00% 46 Buy RatingsCompanies Covered20 Unique Companies Ratings Distribution50RatingsDistribution of strong buy, buy, hold, and sell ratings by Roy Buchanan.RatingPercentageCount Strong Buy0.0%0 ratings Buy92.0%46 ratings Hold8.0%4 ratings Sell0.0%0 ratingsOut of 50 total stock ratings issued by Roy Buchanan at JMP Securities, the majority (92.0%) have been Buy recommendations, followed by 8.0% Hold.Best & Worst CallsBest Call0000.0%CLVSApr 2016Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call000.0%NVUSApr 2016Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNASDAQ90.0% of companies on NASDAQ18 companiesNYSE5.0% of companies on NYSE1 companyNYSEMKT5.0% of companies on NYSEMKT1 companyRoy Buchanan, an analyst at JMP Securities, currently covers 20 companies listed on NASDAQ, NYSE and NYSEMKT, with the majority traded on NASDAQ.Coverage FocusSector IconSectorPercentageMedical19 companies95.0%Finance1 company5.0%Roy Buchanan of JMP Securities specializes in stock coverage within the Medical sector, with additional focus on Finance companies.Coverage IndustriesIndustryPercentageMED - BIOMED/GENE6 companies30.0%MED - DRUGS5 companies25.0%PHARMACEUTICAL PREPARATIONS4 companies20.0%BIOTECHNOLOGY2 companies10.0%MED - GENERIC DRG1 company5.0%FIN - INVEST MGMT1 company5.0%BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC1 company5.0% Roy Buchanan's Ratings History at JMP Securities Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter Export to Excel CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsCDTXCidara Therapeutics9/24/2025Set Price Target$88.30$153.00$0.0000.00% ROIASMBAssembly Biosciences9/24/2025Initiated Coverage$25.99$38.00Market Outperform$0.0000.00% ROIDVAXDynavax Technologies8/22/2025Reiterated Rating$10.95$32.00Market Outperform$0.0000.00% ROIENTAEnanta Pharmaceuticals8/12/2025Boost Price Target$6.49$25.00Market Outperform$0.0000.00% ROICDTXCidara Therapeutics8/8/2025Boost Price Target$61.60$66.00Market Outperform$0.0000.00% ROIDVAXDynavax Technologies8/8/2025Boost Price Target$10.15$32.00Market Outperform$0.0000.00% ROICDTXCidara Therapeutics6/30/2025Reiterated Rating$49.45$59.00Market Outperform$0.0000.00% ROIPYPDPolyPid6/17/2025Lower Price Target$3.53$14.00Market Outperform$0.0000.00% ROIENTAEnanta Pharmaceuticals6/3/2025Boost Price Target$7.09$24.00Market Outperform$0.0000.00% ROICDTXCidara Therapeutics6/2/2025Reiterated Rating$21.56$47.00Market Outperform$0.0000.00% ROI Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. CVACCureVac5/28/2025Reiterated Rating$4.38$10.00Market Outperform$0.0000.00% ROICDTXCidara Therapeutics5/27/2025Reiterated Rating$24.28$47.00Market Outperform$0.0000.00% ROICDTXCidara Therapeutics5/9/2025Boost Price Target$18.90$47.00Market Outperform$0.0000.00% ROIDVAXDynavax Technologies5/7/2025Lower Price Target$9.65$31.00Market Outperform$0.0000.00% ROIANTX(ANTX)5/5/2025Lower Price Target$1.23$2.00Market Outperform$0.0000.00% ROICDTXCidara Therapeutics4/29/2025Reiterated Rating$20.98$46.00Market Outperform$0.0000.00% ROICDTXCidara Therapeutics3/12/2025Set Price Target$22.98$46.00$0.0000.00% ROICVACCureVac2/14/2025Reiterated Rating$3.63$16.00Market Outperform$0.0000.00% ROITPGTPG2/13/2025Reiterated Rating$60.16Market Perform$0.0000.00% ROIESPREsperion Therapeutics2/11/2025Reiterated Rating$1.74$4.00Market Outperform$0.0000.00% ROIENTAEnanta Pharmaceuticals2/11/2025Reiterated Rating$5.64$21.00Market Outperform$0.0000.00% ROIANTX(ANTX)2/3/2025Reiterated Rating$1.14$5.00Market Outperform$0.0000.00% ROIIRWDIronwood Pharmaceuticals1/30/2025Lower Price Target$3.72$14.00Market Outperform$0.0000.00% ROIESPREsperion Therapeutics1/23/2025Reiterated Rating$2.16$7.00Market Outperform$0.0000.00% ROIABVXAbivax1/10/2025Reiterated Rating$6.63$33.00Market Outperform$0.0000.00% ROIINOInovio Pharmaceuticals1/10/2025Reiterated Rating$2.01$18.00Market Outperform$0.0000.00% ROI Stock Forecasts and Research Tools Today's Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
